Global Starch Softgel Capsules Market Insights, Forecast to 2028

The starch soft gel capsules are usually derived from natural sources and are used as nutritional supplements for patients suffering from various medical conditions. These soft gel capsules are usually free of genetic modifications and are manufactured adhering to strict quality standards. The soft gel capsules are available in gelatin as well as non-gelatin composition for people with vegetarian and non-vegetarian preferences.
Market Analysis and Insights: Global Starch Softgel Capsules Market
Due to the COVID-19 pandemic, the global Starch Softgel Capsules market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Gelatin Composition accounting for % of the Starch Softgel Capsules global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Supermarket and Hypermarket segment is altered to an % CAGR throughout this forecast period.
China Starch Softgel Capsules market size is valued at US$ million in 2021, while the US and Europe Starch Softgel Capsules are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Starch Softgel Capsules landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Starch Softgel Capsules include Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd., Procaps, CAPTEK Softgel International Inc., Softcaps, Fuji Capsule Co., Ltd., Aenova Holding GmbH and Sirio Pharma Co., Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Starch Softgel Capsules Scope and Segment
Starch Softgel Capsules market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Starch Softgel Capsules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Gelatin Composition
Non-Gelatin Composition
Segment by Application
Supermarket and Hypermarket
Pharmacy and Drugstore
Online Provider
By Company
Catalent Inc
Robinson Pharma, Inc.
Hunan Er-Kang Pharmaceutical Co., Ltd.
Procaps
CAPTEK Softgel International Inc.
Softcaps
Fuji Capsule Co., Ltd.
Aenova Holding GmbH
Sirio Pharma Co., Ltd.
Bahrain Pharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE